nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—polycystic ovary syndrome	0.981	1	CbGaD
Thiabendazole—CYP1A1—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00195	0.114	CbGpPWpGaD
Thiabendazole—Lansoprazole—CYP1A1—polycystic ovary syndrome	0.00175	1	CrCbGaD
Thiabendazole—CYP1A1—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00108	0.0635	CbGpPWpGaD
Thiabendazole—CYP1A1—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.000834	0.0489	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000506	0.0297	CbGpPWpGaD
Thiabendazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—polycystic ovary syndrome	0.000367	0.0215	CbGpPWpGaD
Thiabendazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—polycystic ovary syndrome	0.000334	0.0196	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.000323	0.0189	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000277	0.0163	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—TEAD2—polycystic ovary syndrome	0.000263	0.0154	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—TEAD2—polycystic ovary syndrome	0.000257	0.0151	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—polycystic ovary syndrome	0.000249	0.0146	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000212	0.0124	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000211	0.0124	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000194	0.0113	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000192	0.0112	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000191	0.0112	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000181	0.0106	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00018	0.0105	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000178	0.0104	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—TEAD2—polycystic ovary syndrome	0.000177	0.0104	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IGFBP1—polycystic ovary syndrome	0.000177	0.0104	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000176	0.0103	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000176	0.0103	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00017	0.00994	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000157	0.0092	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	0.000146	0.00855	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000146	0.00855	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000142	0.00835	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000141	0.00824	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.000135	0.0079	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—SULT2A1—polycystic ovary syndrome	0.000135	0.00789	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SULT2A1—polycystic ovary syndrome	0.000132	0.00772	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.000131	0.00767	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—YAP1—polycystic ovary syndrome	0.000126	0.00736	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000123	0.00723	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—polycystic ovary syndrome	0.000123	0.00721	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000122	0.00714	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000116	0.00678	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000115	0.00677	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000115	0.00673	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000113	0.00664	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000112	0.00658	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—SULT2A1—polycystic ovary syndrome	0.000103	0.00601	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000101	0.00591	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0001	0.00586	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	9.41e-05	0.00552	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—polycystic ovary syndrome	9.31e-05	0.00545	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	9.3e-05	0.00545	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.28e-05	0.00544	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	9.08e-05	0.00532	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SULT2A1—polycystic ovary syndrome	9.08e-05	0.00532	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	9.06e-05	0.00531	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	9.06e-05	0.00531	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—polycystic ovary syndrome	9.06e-05	0.00531	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	8.96e-05	0.00525	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	8.93e-05	0.00523	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	8.72e-05	0.00511	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	8.56e-05	0.00502	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—polycystic ovary syndrome	8.47e-05	0.00497	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	8.47e-05	0.00496	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.34e-05	0.00489	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.22e-05	0.00482	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.77e-05	0.00455	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.75e-05	0.00454	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.64e-05	0.00448	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—NCOR1—polycystic ovary syndrome	7.46e-05	0.00437	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	7.36e-05	0.00431	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	7.32e-05	0.00429	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	7.3e-05	0.00428	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	7.22e-05	0.00423	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	7.06e-05	0.00414	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	7.06e-05	0.00414	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	6.94e-05	0.00407	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	6.65e-05	0.0039	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	6.43e-05	0.00377	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.13e-05	0.00359	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.05e-05	0.00354	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—SULT2A1—polycystic ovary syndrome	6e-05	0.00352	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	5.93e-05	0.00348	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	5.92e-05	0.00347	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	5.92e-05	0.00347	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	5.7e-05	0.00334	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	5.61e-05	0.00329	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	5.46e-05	0.0032	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	5.35e-05	0.00314	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—polycystic ovary syndrome	5.34e-05	0.00313	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP11A1—polycystic ovary syndrome	5.32e-05	0.00312	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	5.24e-05	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	5.23e-05	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	5.03e-05	0.00295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	4.95e-05	0.0029	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	4.94e-05	0.0029	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	4.87e-05	0.00286	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	4.55e-05	0.00267	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	4.5e-05	0.00264	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	4.5e-05	0.00264	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	4.43e-05	0.00259	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NMNAT3—polycystic ovary syndrome	4.35e-05	0.00255	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	4.24e-05	0.00249	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	4.15e-05	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	4.06e-05	0.00238	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPCAT2—polycystic ovary syndrome	3.98e-05	0.00233	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SUOX—polycystic ovary syndrome	3.98e-05	0.00233	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	3.93e-05	0.0023	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	3.91e-05	0.00229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	3.86e-05	0.00226	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	3.77e-05	0.00221	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ISYNA1—polycystic ovary syndrome	3.7e-05	0.00217	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—POMC—polycystic ovary syndrome	3.69e-05	0.00216	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.61e-05	0.00212	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	3.6e-05	0.00211	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	3.58e-05	0.0021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	3.41e-05	0.002	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.37e-05	0.00198	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.2e-05	0.00188	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.15e-05	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TEAD2—polycystic ovary syndrome	3.14e-05	0.00184	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C2—polycystic ovary syndrome	3.14e-05	0.00184	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.11e-05	0.00182	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.02e-05	0.00177	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	2.98e-05	0.00174	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.9e-05	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	2.77e-05	0.00162	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.65e-05	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PNPLA2—polycystic ovary syndrome	2.63e-05	0.00154	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.59e-05	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	2.54e-05	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	2.54e-05	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.5e-05	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SRD5A1—polycystic ovary syndrome	2.5e-05	0.00146	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—STAR—polycystic ovary syndrome	2.38e-05	0.0014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	2.36e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.36e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	2.35e-05	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.3e-05	0.00135	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.15e-05	0.00126	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMMR—polycystic ovary syndrome	2.12e-05	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.04e-05	0.0012	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD3B1—polycystic ovary syndrome	2.03e-05	0.00119	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	2e-05	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	2e-05	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2e-05	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.93e-05	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.9e-05	0.00111	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LHB—polycystic ovary syndrome	1.85e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.81e-05	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.75e-05	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	1.68e-05	0.000984	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	1.61e-05	0.000943	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	1.59e-05	0.000933	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	1.56e-05	0.000913	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	1.52e-05	0.00089	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	1.5e-05	0.000881	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.5e-05	0.00088	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	1.44e-05	0.000846	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.44e-05	0.000841	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.43e-05	0.000835	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.42e-05	0.000829	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.35e-05	0.000794	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.35e-05	0.000789	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.33e-05	0.000777	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.29e-05	0.000757	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.28e-05	0.000748	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.21e-05	0.000709	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.18e-05	0.00069	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.15e-05	0.000675	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.15e-05	0.000672	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.12e-05	0.000654	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1.12e-05	0.000653	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	1.05e-05	0.000615	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	1.03e-05	0.000601	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	9.94e-06	0.000582	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	9.58e-06	0.000561	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	9.36e-06	0.000549	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	9.21e-06	0.000539	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.15e-06	0.000536	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	9.09e-06	0.000533	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.03e-06	0.000529	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	8.92e-06	0.000523	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	8.59e-06	0.000503	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	8.45e-06	0.000495	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	7.88e-06	0.000462	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TH—polycystic ovary syndrome	7.31e-06	0.000429	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	7.11e-06	0.000417	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.69e-06	0.000392	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	6.39e-06	0.000375	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	6.3e-06	0.000369	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—polycystic ovary syndrome	6.27e-06	0.000367	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.97e-06	0.00035	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.69e-06	0.000333	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	5.39e-06	0.000316	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	5.03e-06	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	4.08e-06	0.000239	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	4.02e-06	0.000236	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—polycystic ovary syndrome	4e-06	0.000234	CbGpPWpGaD
